Atlas Trials

Dapagliflozin Therapy In Cardiac Surgery

Clinical trial NCT05621551 · COMPLETED

Trial details

NCT number
NCT05621551
Sponsor
China National Center for Cardiovascular Diseases
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Cardiac Surgery
Start date
2022-11-11
Primary completion
2024-06-01
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.